TrialJournal of diabetes and its complications

Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study.

Mamta Jaiswal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.